Phuong Khanh (P.K.) Morrow, M.D.
Board Member
Lantheus Holdings, Inc. (LNTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Phuong Khanh (P.K.) Morrow, M.D.
Phuong Khanh (P.K.) Morrow, M.D. is recorded as Board Member at Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. reported in an 8-K filed January 30, 2025 that Phuong Khanh (P.K.) Morrow, M.D. was appointed Class II Director, effective January 29, 2025.
“On January 29, 2025, the board of directors of Lantheus Holdings, Inc. (the "Board"), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Phuong Khanh (P.K.) Morrow, M.D., an experienced pharmaceutical executive and physician-scientist with deep expertise leading end-to-end clinical development in the field of oncology, to the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lantheus Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Markison CEO, Chairman, Board Member
- Mary Anne Heino CEO, Chairman, Board Member
- Robert Marshall CFO
- Paul Blanchfield COO
- Daniel M. Niedzwiecki General Counsel
- Andrea Sabens Chief Accounting Officer
- Kimberly Brown Chief Accounting Officer
- Dr. Gérard Ber Board Member
- Dr. James H. Thrall Board Member
- Dr. Phuong Khanh (P.K.) Morrow Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.